HR Execs on the Move

Amneal

www.amneal.com

 
Amneal (NYSE:AMRX) is building one of the most dynamic pharmaceutical companies in our industry. Today`s healthcare environment requires new ideas. While staying true to our reputation for quality, service and value in pharmaceuticals, we are challenging ourselves, our playbook and the status quo. We are uniting people, passion and products to deliver outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrow`s health challenges. We are Amneal and “We make healthy possible.” Learn more about how we`re making a difference in generics, brands and biosimilars at Amneal.com.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.amneal.com
  • 400 Crossing Boulevard 3rd Floor
    Bridgewater, NJ USA 08807
  • Phone: 908.947.3120

Executives

Name Title Contact Details
Manuel Monge
 Vice President Human Resources Profile
Joseph Lingle
 Vice President, Human Resources Profile
Damaris Cadawallader
 Director, Human Resources Profile
Dipen Desai
 Vice President, Complex Product R&D Profile
Bhavika Patel
 Director Analytical R&D Profile

Similar Companies

Paragon28

Paragon 28 was established for unmet needs of the foot and ankle community. Dedicated to creating solutions to improve the treatment of foot and ankle conditions.

Hoveround

The company, founded in 1992 by former nurse and inventor Tom Kruse, is based in Sarasota, Florida.

Lucentis

Lucentis is a South San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Atmos-Tech Industries

Atmos- Tech Industries offers high quality controlled environment and cleanroom products and superior customer service.

Pliant Therapeutics

Pliant Therapeutics is focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases. By harnessing the therapeutic potential of integrin biology and TGF-β modulation, Pliant aims to prevent or even reverse fibrosis to address the needs of many patients. The company also aims to build a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery. Pliant`s co-founders include world-renowned researchers from University of California, San Francisco (UCSF), who bring broad experience in fibrosis biology and small molecule chemistry. Together, the Pliant team is dedicated to translating scientific advances in fibrosis biology into novel therapies for patients in need.